SII

The firm is reducing the price of each dose from Rs 900 to Rs 225 plus Goods and Services Tax (GST) for private hospitals. In…

India's drug regulator had approved Covovax for restricted use in emergency situations in adults on 28th December last year and in…

The firm has written to the Ministry of Health and Family Welfare (MoH&FW) that if these 10 crore free doses of Covishield are…

Adar Poonawalla, CEO, SII also pitched for a global pact for vaccine utilisation

India's drug regulator had approved Covovax for restricted use in emergency situations in adults on 28th December, 2021, and those…

Prakash Kumar Singh, Director, Government and Regulatory Affairs, SII, had put in an application to the DCGI on 6th January…

Novavax has filed the complete CMC data package, which leverages Novavax's manufacturing partnership with the Serum Institute of…

The vaccine will be manufactured and marketed in India by SII under the brand name Covovax

Serum Institute of India (SII) had sent an application to the DCGI in October for the grant of market authorisation of Covovax for…

The Serum Institute of India (SII) had put in an application to the Drugs Controller General of India (DCGI) in October for grant…